| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Baumal Caroline | Chief Medical Officer | C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM | /s/ David Watson, attorney-in-fact for Caroline Baumal | 06 Jan 2026 | 0001961100 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | APLS | Common Stock | Sale | $77,097 | -3,020 | -3.2% | $25.53 | 91,206 | 05 Jan 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 3, 2026. |
| F2 | This includes 925 shares from October 31, 2025 ESPP purchase. |